The analysis of global hospital discharges for malignant neoplasm of the colon, rectum, and anus reveals that Austria leads with 239.4 discharges per 100,000 persons, while Israel is at the lower end with 36.7. Year-on-year data from 2023 showed an increase in Slovakia (1.29%) and Poland (1.85%), while Austria and Finland experienced slight declines. Finland fell by 1.21%, and Israel saw the most significant decrease of 4%. Notably, Belgium and Canada recorded a 0.84% decline in hospital discharges. Five-year trends indicate varying CAGRs across countries, signifying different national healthcare strategies and challenges.
Future trends to watch in this domain include:
- Advancements in early detection and treatment, potentially reducing discharge rates in countries with currently high values.
- Healthcare policy changes in individual countries that could impact hospital discharge rates either positively or negatively.
- Demographic shifts, such as aging populations, which might increase the demand for hospital services for neoplasm-related conditions.
Top countries in Hospital Discharges for Malignant Neoplasm of Colon, Rectum and Anus by Country
| # | 10 Countries | Units (Hospital Discharges) Per Hundred Thousand Persons | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Austria | 239.4 | 2023 | +0.042% | -1.38% | View data |
| 2 | 2 Slovakia | 212.1 | 2023 | +3.77% | +1.29% | View data |
| 3 | 3 Poland | 140.8 | 2023 | +1.59% | +1.85% | View data |
| 4 | 4 Norway | 140.2 | 2023 | 0% | +0.82% | View data |
| 5 | 5 Finland | 124.6 | 2023 | -0.72% | -1.21% | View data |
| 6 | 6 Iceland | 103.3 | 2023 | +0.88% | +2.3% | View data |
| 7 | 7 Spain | 101.2 | 2023 | +4.44% | +0.2% | View data |
| 8 | 8 Belgium | 83.9 | 2023 | +1.57% | -0.84% | View data |
| 9 | 9 Ireland | 60.1 | 2023 | +4.16% | +0.27% | View data |
| 10 | 10 Chile | 56.7 | 2023 | +5.78% | +2.14% | View data |
